பரிணாம வளர்ச்சி உயிரியல் இல் ப்ரிந்ஸ்டந் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
President Biden Announces Members of President s Council of Advisors on Science and Technology
whitehouse.gov - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from whitehouse.gov Daily Mail and Mail on Sunday newspapers.
Biden announces new cadre of outside science advisers
eenews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eenews.net Daily Mail and Mail on Sunday newspapers.
Gary “Hoov” Hoover, the director of Tulane University’s Murphy Institute and a leading economist on issues of economic policy and its impact on inequality, is among a group of 40 Nobel Prize laureates and global innovators selected for the inaugural Nobel Prize Summit, April 26-28, 2021. Registration for the virtual summit is free and open to the public. Please click here for more information or to register for the event.
The Nobel Prize Summit, “Our Planet, Our Future,” will feature a collection of Nobel Prize laureates and esteemed leaders in the sciences, policy, business, the youth movement and the arts to explore actions that can be achieved in this decade to put the world on a path to a more sustainable, more prosperous future for all.
D&R Greenway Land Trust joins newest partner in - Princeton, NJ Patch
patch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from patch.com Daily Mail and Mail on Sunday newspapers.
Date Time
Gene-editing produces tenfold increase in superbug slaying antibiotics
Scientists have used gene-editing advances to achieve a tenfold increase in the production of super-bug targeting formicamycin antibiotics.
The John Innes Centre researchers used the technology to create a new strain of Streptomyces formicae bacteria which over-produces the medically promising molecules.
Discovered within the last ten years, formicamycins have great potential because, under laboratory conditions, superbugs like MRSA do not become resistant to them.
However, Streptomyces formicae only produce the antibiotics in small quantities. This has made it difficult to scale up purification for further study and is an obstacle to the molecules being taken forward for clinical trials.